Product Description
Since last many yearsSaintroy Lifescience is leading manufacture, export and supplierofTeniposide Injection from Surat, Gujarat, India. Teniposide Injection used for the treatment of a number of cancer types in children.
Tags: Teniposide Injection manufacturer, Teniposide Injection exporter,Teniposide Injection supplier, and Teniposide Injection, whogmp approved Teniposide Injectionmanufacturer and supplier, Teniposide Injection distributor, Teniposide Injectionshipper, Teniposide Injection 5 ml Teniposide Injection 5 ml supplier,Teniposide Injection 5 ml.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturingfacility in Gujarat, India.
Registration: Saintroy Lifescience is interested in registrationof own brand or customer brands in ministry of health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country :Saintroy Lifescience Teniposide Injection Exportto USA, Canada, Germany, Europe, France, Ghana, Nigeria, Kenya, Senegal,Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile, Somalia, Philippines,Myanmar, Maldives, Thailand, Singapore, Malaysia, Hong Kong, China, Zimbabwe,Togo, Burkina Faso, Niger,Guinea Bissau, Congo, Democratic of republic, IvoryCosta, Oman, Guatemala, Nicaragua, Salvador, Qatar, Costa Rica, Panama, Cuba,Colombia, Bolivia, Argentine, Algeria, Guyana, Morocco, Jordan, Bahrain, Iran,Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Precise Cancer Treatment SolutionTeniposide Injection is designed to address acute lymphoblastic leukemia and potentially other cancer types. The formulation, which comes as a clear solution, ensures accurate dosing and controlled infusion. Healthcare professionals rely on this intervention, adjusting dosage based on individual renal and hepatic function, for effective and targeted treatment. Its compatibility with standard IV fluids simplifies administration across healthcare settings.
Safe Handling and AdministrationGiven its cytotoxic properties, Teniposide Injection must be handled with stringent precautions. Medical staff should use appropriate protective gear when preparing and administering the medication. The product is available in single-dose vials, minimizing contamination risks, and is prescribed and administered under strict medical supervision to ensure patient and staff safety.
Convenient Storage and Shelf LifeTeniposide Injection is formulated for a two-year shelf life, provided it is kept in a cool, dry environment away from direct sunlight. Such storage ensures the medication maintains its efficacy and safety profile, which is particularly important for hospitals, clinics, and pharmaceutical suppliers managing cancer treatment inventory.
FAQ's of Teniposide Injection:
Q: How is Teniposide Injection administered for cancer treatment?
A: Teniposide Injection is administered intravenously (IV) as an infusion by a healthcare professional, ensuring precise delivery into the bloodstream for the treatment of conditions like acute lymphoblastic leukemia.
Q: What precautions are necessary when handling Teniposide Injection?
A: Because Teniposide is cytotoxic, protective equipment such as gloves and gowns should be worn during preparation and administration to prevent accidental exposure.
Q: When is dosage adjustment required for Teniposide Injection?
A: Dosage adjustments are essential for patients with impaired kidney or liver function, as these organs play a significant role in metabolizing and clearing the drug from the body.
Q: Where should Teniposide Injection be stored for optimal stability?
A: It should be kept in a cool, dry place and protected from light. Always follow the specific storage instructions to maintain the medication's potency and shelf life.
Q: What are the benefits of Teniposide Injection in cancer therapy?
A: Teniposide Injection provides effective control of certain cancers, particularly acute lymphoblastic leukemia, by inhibiting cancer cell growth in a targeted manner under close medical supervision.
Q: Is Teniposide Injection suitable for use during pregnancy or breastfeeding?
A: Teniposide is generally not recommended during pregnancy or breastfeeding unless absolutely essential, due to potential risks to the fetus or infant. Its use should be closely evaluated by a healthcare provider.
Q: What fluids are compatible for diluting Teniposide Injection before infusion?
A: Teniposide Injection can be diluted using either 5% dextrose or 0.9% sodium chloride injection to prepare it for safe and effective IV administration.